News

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The FDA announced that it would only allow COVID-19 vaccinations for those 65 years of age and over and those with certain ...
Dr. Matthew Sims, the Director of Infectious Diseases Research at Corewell Health talks with us about the new requirements ...
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Amidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer ...
The new wave of Covid-19 infections across many cities in Southeast Asia is mainly driven by new Omicron sub-variants, particularly JN.1 and its descendants such as LF.7 and NB.1.8. According to ...